Tata Nifty MidSmall Healthcare Index Fund - Regular Plan - IDCW Payout
Category: Index Fund
Launch Date: 26-04-2024
AUM:
₹ 156.69 Cr
Expense Ratio
1.11%
Benchmark
NIFTY 100 Equal Weight TRI
ISIN
INF277KA1BE8
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
500
Fund Manager
1. Kapil Menon, 2. Rakesh Prajapati
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Tata Nifty MidSmall Healthcare Index Fund - Regular Plan - IDCW Payout | 3.72 | - | - |
| NIFTY 100 Equal Weight TRI | -2.58 | 17.94 | 22.39 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
13.0548
Last change
-0.06 (-0.4473%)
Fund Size (AUM)
₹ 156.69 Cr
Performance
20.55% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the scheme is to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The scheme does not assure or guarantee any returns
Fund Manager
1. Kapil Menon, 2. Rakesh Prajapati
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 14.54 |
| FORTIS HEALTHCARE LIMITED. EQ | 8.05 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 7.77 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 5.68 |
| GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | 4.91 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 4.87 |
| ALKEM LABORATORIES LIMITED EQ | 4.84 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 4.73 |
| BIOCON LIMITED EQ | 3.55 |
| IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- | 3.26 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 100.13 |